Commercial Demand for Microgravity Drug Discovery Accelerates as Exobiosphere and Voyager Add Two Missions to the ISS

Voyager Technologies (NYSE: VOYG) and Exobiosphere today announced two additional research campaigns aboard the International Space Station, expanding an agreement that is turning commercial biotech research in microgravity into a recurring, schedulable service rather than a one-off opportunity.Exo…